Putnam Investments’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
SCM
Putnam Investments's HALO Position: Q4 2023 in Review
Putnam Investments increased its Halozyme (HALO) stake by 1.9% in Q4 2023, buying an estimated $187K and bringing the position to 272,146 shares worth $10.1M. The position accounts for 0.01% of the portfolio, ranked #325.
Putnam Investments first reported a position in HALO in Q3 2015 and has held it in 20 quarters since. The position peaked at $17.6M in Q4 2022. 410 funds tracked by Wall St. Rank hold HALO as of Q4 2023.
- Putnam Investments held 272,146 shares of Halozyme worth $10.1M as of Q4 2023.
- Putnam Investments bought 4,955 Halozyme shares in Q4 2023, an estimated $187K.
- Halozyme made up 0.01% of Putnam Investments's portfolio in Q4 2023, its #325 holding.
- Putnam Investments first reported a position in Halozyme in Q3 2015 and has held it in 20 quarters since.
- Putnam Investments's Halozyme position peaked at $17.6M in Q4 2022.
- 410 funds tracked by Wall St. Rank held Halozyme as of Q4 2023.
Based on Putnam Investments's 13F filing for Q4 2023, filed 14 Feb 2024.